ASN
CCXI

Advisory Services Network’s ChemoCentryx, Inc. CCXI Stock Holding History

Advisory Services Network’s Portfolio CCXI Stock Details CCXI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-500
Closed -$7K – 3548
2021
Q2 		$7K Buy
+500
New +$12.3K ﹤0.01% 2981

Other funds holding CCXI

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Voloridge Investment Management
Voloridge Investment Management Jupiter, Florida $25B AUM 28.08% 1-Year Est. Return

Advisory Services Network's CCXI Position: Q3 2021 in Review

Advisory Services Network sold out of ChemoCentryx, Inc. (CCXI) in Q3 2021, closing a stake of 500 shares — an estimated $7K sold.

Advisory Services Network first reported a position in CCXI in Q2 2021 and held it in 1 quarter. The position peaked at $7K in Q2 2021. 140 funds tracked by Wall St. Rank hold CCXI as of Q3 2021.

  • Advisory Services Network reported no remaining ChemoCentryx, Inc. position as of Q3 2021 after selling out during the quarter.
  • Advisory Services Network sold 500 ChemoCentryx, Inc. shares in Q3 2021, an estimated $7K.
  • Advisory Services Network first reported a position in ChemoCentryx, Inc. in Q2 2021 and held it in 1 quarter.
  • Advisory Services Network's ChemoCentryx, Inc. position peaked at $7K in Q2 2021.
  • 140 funds tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q3 2021.

Based on Advisory Services Network's 13F filing for Q3 2021, filed 5 Nov 2021.